La Jolla, California 92037


Purpose:

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on pain and functionality in people with rheumatoid arthritis (RA). SVF contains multiple cellular components, including stem cells, with both regenerative and anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of RA. This study is designed to evaluate changes in pain and functionality in individuals with RA for up to 12 months following SVF treatment.


Criteria:

Inclusion Criteria: - Subjects diagnosed with rheumatoid arthritis - Subjects scheduled for a stem cell/SVF treatment - Subjects willing and able to sign informed consent - Subjects willing and able to perform follow-up interviews and surveys Exclusion Criteria: - Subjects with addition major health condition/disease diagnoses - Subjects that are pregnant or breastfeeding


NCT ID:

NCT02348086


Primary Contact:

Holly Bergen
Phone: 800-609-7795


Backup Contact:

N/A


Location Contact:

La Jolla, California 92037
United States

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.